CL-82198, a selective MMP-13 inhibitor, serves as a pharmacological intervention to halt the progression of osteoarthritis (OA). Its mechanism of action involves binding to the S1' pocket of MMP-13, ensuring its selectivity and preventing inhibition of other MMPs.
Marketplace OffersShowing from 3 suppliers
Supplier
TargetMolSC
Pack Size
Estimated Lead Time
1-3 days
Purity
95.91%
$ 40.00
1
Supplier
EnamineSC
Pack Size
Estimated Lead Time
4-6 weeks
Purity
-
$ 169.44
1
Supplier
Princeton BioMolecal ResearchBB
Pack Size
Estimated Lead Time
4-6 weeks
Purity
-
$ 1,513.00
1
You cannot determine which compound library is the best fit for your project? Do you need a custom solution? AnyMol is always ready to help you.